Discussing Details of ATMF’s 2021 AMR Benchmark Report!
Dear All, As you may remember, last fall I wrote a newsletter about ATMF’s 3rd update to the AMR Benchmark series. You are encouraged to read the
24 February 2022
No Comments
R&D Insight
EPA (Part 4): Further resources
This is the fourth of a 5-part newsletter series. There is an initial 27 Sep 2023 newsletter introducing the EPA concept note, a second (28 Sep 2023) newsletter that expands on
27 January 2024
No Comments
Non-traditional antibiotics: A pipeline review and an analysis of key development challenges
Dear All, Non-traditional alternatives to antibiotics have excited a lot of interest in the past few years but we’ve seen relatively few of these progress
6 August 2019
No Comments
Stewardship & Access Guide from CARB-X, Wellcome, and partners: Analysis, video chat
Dear All, Novel antibacterial agents, vaccines, and diagnostics will do little if they are not widely available and used responsibly. CDDEP’s recent report entitled “The
22 March 2021
No Comments
FDA AdComm #2 on inhaled ciprofloxacin (11 Jan 2018); IMI Call for AMR diagnostics (28 Feb 2018 deadline)
Dear All: Two new events on the near-term horizon. First, FDA has announced an Antimicrobial Drugs Advisory Committee for 11 Jan 2018 (and materials from the meeting
3 December 2017
No Comments
CARB-X Novel Chemistry for AMR Challenge
Dear All, Happy New Year! As a great start for January, Team CARB-X have announced (i) that they will have two funding calls during 2026 (April
8 January 2026
No Comments
Impact of PASTEUR: 9.9m lives saved, ROI of 125:1
Dear All (and with thanks to Kevin Outterson for being lead author on this newsletter), (wonkish alert on this one … refresh your coffee and
29 November 2022
No Comments
The threat of mirror bacteria: Ongoing conversations (July 2025)
Dear All (addendum: see also the 22 Dec 2025 follow-up newsletter), I wrote in a 12 Dec 2024 newsletter (“Mirror Bacteria: An AMR threat of unprecedented
18 July 2025
No Comments
48,015 → 0: Antibacterial discovery is hard. Really, really hard.
Dear All (and with thanks to Patricia Bradford for co-authoring this newsletter), When you are seeking novelty, antibacterial discovery is hard … really, really, REALLY
9 April 2024
No Comments
Help design GAMRIC 2026! Webinar on Tue 16 Dec
Note: As always, please use the copy of the newsletter posted at https://amr.solutions/ if you have trouble with links in this newsletter. Dear All, As I
12 December 2025
No Comments